Cold Chain Failures Cost $35 billion Annually – why is this acceptable?

Packaging failures, infrastructure breakdowns, and weather events all play a part. Yet, one of the most avoidable culprits is customs delay.

“Customs delays are a major root cause of temperature deviations, leading to product damage,” says John Coleman, Head of Life Science at YSDS. “Products are often held for extended periods, causing packaging to exceed its validated duration, or stored at incorrect temperatures during the delay. These are situations that can be avoided with better preparation.”

The paradox is striking. Companies devote years and billions to developing therapies, running trials with meticulous precision and meeting the most demanding regulatory standards. Yet when it comes to logistics, documentation errors, vague responsibilities, and lack of customs planning are still treated as routine setbacks. If science cannot tolerate uncertainty, why does supply chain management continue to do so?

Customs-related delays are not just about wasted product. Each disruption sets off a cascade of costs: corrective and preventive action (CAPA) reports, re-manufacturing, re-packaging, and stakeholder frustration. Even when product is not lost, the impact can be severe; trials delayed, treatment schedules interrupted, and reputations damaged.

Even when product is not lost, the impact can be severe; trials delayed, treatment schedules interrupted, and reputations damaged.

Greater alignment

The irony is that these failures are often preventable. Assigning one accountable person for customs documentation, pre-clearance reviews, and early preparation can eliminate many risks. Yet too often, logistics remains an afterthought, disconnected from production and trial planning.

Ensuring that all stakeholders are aligned, communicating, and aware of their specific roles throughout the manufacturing and distribution timeline is critical to avoiding delays and improving performance.

The fragmented nature of the supply chain only amplifies the issue. Manufacturers, brokers, logistics providers, and regulators all play a role, yet responsibility often slips between the cracks.

Coleman calls for greater alignment: “Ensuring that all stakeholders are aligned, communicating, and aware of their specific roles throughout the manufacturing and distribution timeline is critical to avoiding delays and improving performance.”

Robust planning and discipline

The life science sector prides itself on innovation, resilience, and progress. It has proven, especially during the COVID-19 pandemic, that global collaboration is possible under pressure. Trade blocs and harmonized systems are making progress toward unified standards. Packaging technology is evolving to buy more time. The expertise and tools are there.

Why is there zero tolerance for errors in clinical data but relative complacency in logistics, where the same rigor could save billions and, more importantly, prevent treatment delays for patients?

Which leads back to the fundamental question: why does the industry continue to accept billions in avoidable waste? Why is there zero tolerance for errors in clinical data but relative complacency in logistics, where the same rigor could save billions and, more importantly, prevent treatment delays for patients?

For Coleman, the solution is less about invention and more about discipline. “The thing that could save your shipment is how robust your planning has been beforehand, ensuring back-up solutions for when things do go wrong.”

Cold chain failures may never be eliminated, but reducing them requires the same uncompromising mindset that governs every other stage of the life science process. Until the industry stops treating logistics as a cost center and starts treating it as a core element of patient safety, the $35 billion question will remain: why tolerate the intolerable?

About YSDS Life Science

YSDS Life Science offers GDP-certified solutions for clinical trials, advanced therapies, biotechnology and pharmaceuticals. With deep expertise in GDP-compliant transport, temperature-controlled shipments, time-critical delivery, and customs documentation and preparation, the unit has built a reputation for solving the most complex logistics challenges with precision and care. Services include solutions that ensure the safe and timely transport of temperature-sensitive, high-value shipments in temperatures ranging from cryogenic at -196°C to incubation temperature. Our dedicated team of specialists manage the full scope of requirements for these sensitive transports, from regulatory documentation through to final delivery, ensuring the viability of the product every step of the way.

If you need advice on your next shipment don’t hesitate to reach out: info@ysds.com